JAZZ – jazz pharmaceuticals plc - ordinary shares (US:NASDAQ)
Stock Stats
News
Jazz Pharmaceuticals (JAZZ) had its price target raised by Piper Sandler from $219.00 to $232.00. They now have an "overweight" rating on the stock.
Jazz Pharmaceuticals to present clinical, preclinical data at AACR 2026 [Yahoo! Finance]
A Look At Jazz Pharmaceuticals (JAZZ) Valuation As New Oncology Data Heads To The 2026 AACR Meeting [Yahoo! Finance]
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026 [Yahoo! Finance]
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: COZADD BRUCE C
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: Johnson Philip L
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: Henderson Mary Elizabeth
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: Pearce Samantha
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: Iannone Robert
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.